Multiple labeling of a potent CX3CR1 antagonist for the treatment of multiple sclerosis
Several methods for the preparation of five isotopologues of the CX 3CR1 antagonist 1 were developed. Volatile and radioactive 1-chloro- and 1-bromo-ethyl-benzene was handled in [2′-14C] and [3′, 5′-3H] labeling of 1. d-Le
Malmquist, Jonas,Stroem, Peter
p. 387 - 392,6
(2020/08/24)
More Articles about upstream products of 36724-65-9